Cision PR Newswire

Tianjin University Leads World’s 1st ISO Standard for Single-Herb TCM Formula Granules

TIANJIN, China, Sept. 16, 2026 /PRNewswire/ -- The International Organization for Standardization (ISO) has published ISO 21756:2026, the world's first international standard for single-herb Traditional Chinese Medicine (TCM) formula granules. Titled Traditional Chinese Medicine — Salvia miltiorrhiza Root and Rhizome Aqueous Extract Granules, the standard represents a significant step...

Chunghwa Telecom Receives Frost & Sullivan’s 2026 Taiwanese Customer Value Leadership Recognition for AI-Powered Customer Services

This recognition highlights Chunghwa Telecom's leadership in AI-powered customer services through market-relevant AI innovation,...

Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64

HONG KONG, Sept. 17, 2026 /PRNewswire/ -- Chubb Wealth and S64 have partnered to...

/C O R R E C T I O N — London School of Business & Finance Singapore Campus/

In the news release, LSBF Secures UTAP Funding for SCAQ Programmes, Renews Three-Year Partnership...

CCTV4: 20th China Film Huabiao Awards

BEIJING, April 26, 2025 /PRNewswire/ -- The latest data from the National Film Administration have revealed that the box office revenue of the...

The New DePin: OKZOO’s Environmental AIoT Machine Network Leads New Tech Trend

HO CHI MINH CITY, Vietnam, April 26, 2025 /PRNewswire/ -- The "new DePin" (Decentralized Physical Infrastructure Network) trend is arising, as OKZOO's AIoT devices...

Petal Ads Hosts “Think Tank 2025” Seminar in Japan to Empower Japanese Companies’ Global Expansion

TOKYO, April 26, 2025 /PRNewswire/ -- Petal Ads, Huawei's leading global mobile advertising platform, today successfully hosted the "Think Tank 2025" seminar in...

51Talk Online Education Group Files Annual Report on Form 20-F for Fiscal Year of 2024

SINGAPORE, April 26, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise...

Innovent Announces NMPA Approval of Limertinib, a Third-generation EGFR TKI Collaborated with ASK Pharma, for the First-line Treatment of Lung Cancer

SAN FRANCISCO and SUZHOU,China, April 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...